Insider Buying: Michael H. Tardugno Purchases 5,000 Shares of Celsion Stock (CLSN)
Celsion (NASDAQ:CLSN) CEO Michael H. Tardugno purchased 5,000 shares of Celsion stock on the open market in a transaction that occurred on Wednesday, June 11th. The stock was purchased at an average price of $3.20 per share, for a total transaction of $16,000.00. Following the completion of the acquisition, the chief executive officer now directly owns 62,521 shares in the company, valued at approximately $200,067. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Shares of Celsion (NASDAQ:CLSN) traded up 1.57% on Thursday, hitting $3.23. 21,821 shares of the company’s stock traded hands. Celsion has a 1-year low of $2.82 and a 1-year high of $7.4324. The stock has a 50-day moving average of $3.18 and a 200-day moving average of $3.59. The company’s market cap is $55.6 million.
Celsion (NASDAQ:CLSN) last posted its quarterly earnings results on Thursday, May 8th. The company reported ($0.33) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.24) by $0.09. On average, analysts predict that Celsion will post $-1.39 earnings per share for the current fiscal year.
Celsion Corporation (NASDAQ:CLSN) is an oncology drug development company focused on improving treatment for those suffering with aggressive and difficult to treat forms of cancer.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.